Use of biosimilars in inflammatory bowel disease: a position update of the Italian Group for the Study of Inflammatory Bowel Disease (IG-IBD).
Fiorino, Gionata
Use of biosimilars in inflammatory bowel disease: a position update of the Italian Group for the Study of Inflammatory Bowel Disease (IG-IBD). [electronic resource] - Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver 05 2019 - 632-639 p. digital
Publication Type: Journal Article; Review
1878-3562
10.1016/j.dld.2019.02.004 doi
Adalimumab
Antibodies, Monoclonal--therapeutic use
Biosimilar Pharmaceuticals--chemical synthesis
Humans
Inflammatory Bowel Diseases--drug therapy
Infliximab
Italy
Randomized Controlled Trials as Topic
Societies, Medical
Tumor Necrosis Factor-alpha--antagonists & inhibitors
Use of biosimilars in inflammatory bowel disease: a position update of the Italian Group for the Study of Inflammatory Bowel Disease (IG-IBD). [electronic resource] - Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver 05 2019 - 632-639 p. digital
Publication Type: Journal Article; Review
1878-3562
10.1016/j.dld.2019.02.004 doi
Adalimumab
Antibodies, Monoclonal--therapeutic use
Biosimilar Pharmaceuticals--chemical synthesis
Humans
Inflammatory Bowel Diseases--drug therapy
Infliximab
Italy
Randomized Controlled Trials as Topic
Societies, Medical
Tumor Necrosis Factor-alpha--antagonists & inhibitors